CVS Health Co. (NYSE:CVS) Shares Sold by Kiltearn Partners LLP

Kiltearn Partners LLP decreased its position in CVS Health Co. (NYSE:CVS) by 9.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 716,868 shares of the pharmacy operator’s stock after selling 74,800 shares during the period. CVS Health makes up 6.1% of Kiltearn Partners LLP’s holdings, making the stock its 3rd biggest holding. Kiltearn Partners LLP owned about 0.06% of CVS Health worth $45,077,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of CVS. Pzena Investment Management LLC lifted its position in shares of CVS Health by 132.9% during the 2nd quarter. Pzena Investment Management LLC now owns 12,936,388 shares of the pharmacy operator’s stock valued at $764,023,000 after acquiring an additional 7,382,931 shares during the period. Pathway Financial Advisers LLC raised its holdings in shares of CVS Health by 5,864.2% during the third quarter. Pathway Financial Advisers LLC now owns 1,730,343 shares of the pharmacy operator’s stock valued at $108,804,000 after purchasing an additional 1,701,331 shares during the period. State of Michigan Retirement System boosted its position in shares of CVS Health by 402.5% during the 2nd quarter. State of Michigan Retirement System now owns 2,005,677 shares of the pharmacy operator’s stock worth $118,455,000 after purchasing an additional 1,606,500 shares in the last quarter. Swedbank AB acquired a new stake in shares of CVS Health in the 1st quarter valued at about $110,816,000. Finally, AQR Capital Management LLC increased its position in CVS Health by 33.5% in the 2nd quarter. AQR Capital Management LLC now owns 5,289,788 shares of the pharmacy operator’s stock valued at $310,722,000 after buying an additional 1,327,855 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have commented on CVS shares. Royal Bank of Canada reduced their price objective on CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research note on Friday, November 15th. Truist Financial restated a “buy” rating and set a $67.00 price target (down previously from $76.00) on shares of CVS Health in a research note on Wednesday, November 20th. StockNews.com cut shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Deutsche Bank Aktiengesellschaft lowered their price objective on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Finally, TD Cowen increased their target price on shares of CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a report on Monday. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $70.33.

CVS Health Stock Down 1.8 %

Shares of NYSE CVS opened at $59.02 on Wednesday. The business’s fifty day moving average price is $59.26 and its 200-day moving average price is $58.69. CVS Health Co. has a one year low of $52.71 and a one year high of $83.25. The stock has a market capitalization of $74.27 billion, a PE ratio of 14.98, a P/E/G ratio of 1.01 and a beta of 0.55. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. During the same quarter in the previous year, the firm posted $2.21 earnings per share. The company’s quarterly revenue was up 6.3% compared to the same quarter last year. On average, equities research analysts anticipate that CVS Health Co. will post 5.43 EPS for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.51%. The ex-dividend date was Monday, October 21st. CVS Health’s payout ratio is presently 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.